Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-18-052906

Director acquired 8,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
EASTHAM KARIN Director 2018-09-27 Grant or award +8,500 8,500 D
Derivatives
EASTHAM KARIN Director 2018-09-27 Grant or award · Stock Option +17,000 17,000 D
Loading xslF345X03/doc4.xml…